aidsmap/nam, 25 October 2016
SImplification of an antiretroviral treatment to a boosted protease inhibitor and the nucleoside analogue lamivudine (a dual regimen) is highly effective in people switching from a stable three-drug regimen, researchers reported on Monday at the International Congress on Drug Therapy in HIV Infection (HIV Glasgow).
Read more here
Slate, Sept. 2 2016 1:07 PM For many gay and bi men, it’s a perennial point of contention: Are “minor” sexually transmitted infections—like chlamydia or gonorrhea—a cause for serious concern or major behavior modification? A recent study by the Centers for Disease Control and Prevention, featured in its Morbidity and Mortality Weekly Report, found a significant rise in resistance to one of the...
World Health Organisation, 30 August 2016 STIs present a major burden of disease and negatively affect people’s well-being across the globe. Chlamydia, gonorrhoea and syphilis are three STIs which are all caused by bacteria and which can potentially be cured by antibiotics. Unfortunately, these STIs often go undiagnosed and due to antibiotic resistance, they are also becoming increasingly...
Oxford University, 12 July 2016 With drug-resistant strains of sexually-transmitted infection gonorrhoea increasing, scientists from Brighton, Oxford University and Public Health England have found that genetic sequencing can track the spread of infection. They show coordinated national and international strategies are required to stop drug-resistance spreading further. Their study, funded by the...
May 2016
Responding to antimicrobial resistant gonorrhoea in the community, SA Health have updated their gonococcal treatment guidelines.
The updated Gonorrhoea diagnosis and management guidelines from SA Health can be found here
nam/aidsmap, 25 February 2016
A case report of a man in Toronto who became infected with a multi-drug-resistant strain of HIV despite apparently very consistent adherence to PrEP was presented at the CROI 2016 conference in Boston today.
Read more here